nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Loss of consciousness—Sorafenib—thyroid cancer	0.00264	0.00264	CcSEcCtD
Meropenem—Cough—Sorafenib—thyroid cancer	0.00262	0.00262	CcSEcCtD
Meropenem—Inflammation—Epirubicin—thyroid cancer	0.00261	0.00261	CcSEcCtD
Meropenem—Asthenia—Vandetanib—thyroid cancer	0.0026	0.0026	CcSEcCtD
Meropenem—Hypertension—Sorafenib—thyroid cancer	0.00259	0.00259	CcSEcCtD
Meropenem—Pruritus—Vandetanib—thyroid cancer	0.00257	0.00257	CcSEcCtD
Meropenem—Cough increased—Doxorubicin—thyroid cancer	0.00256	0.00256	CcSEcCtD
Meropenem—Glossitis—Doxorubicin—thyroid cancer	0.00254	0.00254	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00253	0.00253	CcSEcCtD
Meropenem—Vaginal inflammation—Epirubicin—thyroid cancer	0.00253	0.00253	CcSEcCtD
Meropenem—Pulmonary embolism—Epirubicin—thyroid cancer	0.00253	0.00253	CcSEcCtD
Meropenem—Injection site reaction—Epirubicin—thyroid cancer	0.00252	0.00252	CcSEcCtD
Meropenem—Diarrhoea—Vandetanib—thyroid cancer	0.00248	0.00248	CcSEcCtD
Meropenem—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.00248	0.00248	CcSEcCtD
Meropenem—Melaena—Epirubicin—thyroid cancer	0.00248	0.00248	CcSEcCtD
Meropenem—Creatinine increased—Doxorubicin—thyroid cancer	0.00246	0.00246	CcSEcCtD
Meropenem—Anaphylactic shock—Sorafenib—thyroid cancer	0.00245	0.00245	CcSEcCtD
Meropenem—Colitis—Epirubicin—thyroid cancer	0.00243	0.00243	CcSEcCtD
Meropenem—Infection—Sorafenib—thyroid cancer	0.00243	0.00243	CcSEcCtD
Meropenem—Candida infection—Epirubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Meropenem—Inflammation—Doxorubicin—thyroid cancer	0.00242	0.00242	CcSEcCtD
Meropenem—Shock—Sorafenib—thyroid cancer	0.00241	0.00241	CcSEcCtD
Meropenem—Nervous system disorder—Sorafenib—thyroid cancer	0.0024	0.0024	CcSEcCtD
Meropenem—Dizziness—Vandetanib—thyroid cancer	0.0024	0.0024	CcSEcCtD
Meropenem—Thrombocytopenia—Sorafenib—thyroid cancer	0.0024	0.0024	CcSEcCtD
Meropenem—Blood urea increased—Epirubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Meropenem—Vaginal infection—Epirubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Meropenem—Neuropathy—Epirubicin—thyroid cancer	0.00238	0.00238	CcSEcCtD
Meropenem—Skin disorder—Sorafenib—thyroid cancer	0.00238	0.00238	CcSEcCtD
Meropenem—Pulmonary embolism—Doxorubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Meropenem—Vaginal inflammation—Doxorubicin—thyroid cancer	0.00235	0.00235	CcSEcCtD
Meropenem—Anorexia—Sorafenib—thyroid cancer	0.00233	0.00233	CcSEcCtD
Meropenem—Injection site reaction—Doxorubicin—thyroid cancer	0.00233	0.00233	CcSEcCtD
Meropenem—Vomiting—Vandetanib—thyroid cancer	0.00231	0.00231	CcSEcCtD
Meropenem—Melaena—Doxorubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Meropenem—Rash—Vandetanib—thyroid cancer	0.00229	0.00229	CcSEcCtD
Meropenem—Dermatitis—Vandetanib—thyroid cancer	0.00229	0.00229	CcSEcCtD
Meropenem—Headache—Vandetanib—thyroid cancer	0.00227	0.00227	CcSEcCtD
Meropenem—Pulmonary oedema—Epirubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Meropenem—Colitis—Doxorubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Meropenem—Candida infection—Doxorubicin—thyroid cancer	0.00224	0.00224	CcSEcCtD
Meropenem—Vaginal infection—Doxorubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Meropenem—Blood urea increased—Doxorubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Meropenem—Neuropathy—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Meropenem—Sepsis—Epirubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Meropenem—Dyspnoea—Sorafenib—thyroid cancer	0.00218	0.00218	CcSEcCtD
Meropenem—Nausea—Vandetanib—thyroid cancer	0.00215	0.00215	CcSEcCtD
Meropenem—Dyspepsia—Sorafenib—thyroid cancer	0.00215	0.00215	CcSEcCtD
Meropenem—Phlebitis—Epirubicin—thyroid cancer	0.00214	0.00214	CcSEcCtD
Meropenem—Decreased appetite—Sorafenib—thyroid cancer	0.00213	0.00213	CcSEcCtD
Meropenem—Thrombophlebitis—Epirubicin—thyroid cancer	0.00213	0.00213	CcSEcCtD
Meropenem—Blood alkaline phosphatase increased—Epirubicin—thyroid cancer	0.00212	0.00212	CcSEcCtD
Meropenem—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00211	0.00211	CcSEcCtD
Meropenem—Constipation—Sorafenib—thyroid cancer	0.00209	0.00209	CcSEcCtD
Meropenem—Pain—Sorafenib—thyroid cancer	0.00209	0.00209	CcSEcCtD
Meropenem—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Meropenem—Hepatic failure—Epirubicin—thyroid cancer	0.00205	0.00205	CcSEcCtD
Meropenem—Sepsis—Doxorubicin—thyroid cancer	0.00204	0.00204	CcSEcCtD
Meropenem—Gastrointestinal pain—Sorafenib—thyroid cancer	0.002	0.002	CcSEcCtD
Meropenem—Phlebitis—Doxorubicin—thyroid cancer	0.00198	0.00198	CcSEcCtD
Meropenem—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00197	0.00197	CcSEcCtD
Meropenem—Blood alkaline phosphatase increased—Doxorubicin—thyroid cancer	0.00196	0.00196	CcSEcCtD
Meropenem—Urticaria—Sorafenib—thyroid cancer	0.00194	0.00194	CcSEcCtD
Meropenem—Abdominal pain—Sorafenib—thyroid cancer	0.00193	0.00193	CcSEcCtD
Meropenem—Body temperature increased—Sorafenib—thyroid cancer	0.00193	0.00193	CcSEcCtD
Meropenem—Hepatic failure—Doxorubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Meropenem—Cardiac failure—Epirubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Meropenem—Hypoglycaemia—Epirubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Meropenem—Hypersensitivity—Sorafenib—thyroid cancer	0.0018	0.0018	CcSEcCtD
Meropenem—Asthenia—Sorafenib—thyroid cancer	0.00176	0.00176	CcSEcCtD
Meropenem—Cardiac arrest—Epirubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Meropenem—Cardiac failure—Doxorubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Meropenem—Hypoglycaemia—Doxorubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Meropenem—Pruritus—Sorafenib—thyroid cancer	0.00173	0.00173	CcSEcCtD
Meropenem—Blood creatinine increased—Epirubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Meropenem—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Meropenem—Hypokalaemia—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Meropenem—Diarrhoea—Sorafenib—thyroid cancer	0.00167	0.00167	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Meropenem—Cardiac arrest—Doxorubicin—thyroid cancer	0.00162	0.00162	CcSEcCtD
Meropenem—Dizziness—Sorafenib—thyroid cancer	0.00162	0.00162	CcSEcCtD
Meropenem—Abdominal distension—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Meropenem—Blood creatinine increased—Doxorubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Meropenem—Asthma—Epirubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Meropenem—Eosinophilia—Epirubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Meropenem—Vomiting—Sorafenib—thyroid cancer	0.00156	0.00156	CcSEcCtD
Meropenem—Hypokalaemia—Doxorubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Meropenem—Rash—Sorafenib—thyroid cancer	0.00154	0.00154	CcSEcCtD
Meropenem—Dermatitis—Sorafenib—thyroid cancer	0.00154	0.00154	CcSEcCtD
Meropenem—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Meropenem—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Meropenem—Headache—Sorafenib—thyroid cancer	0.00153	0.00153	CcSEcCtD
Meropenem—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.0015	0.0015	CcSEcCtD
Meropenem—Dysuria—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Meropenem—Neutropenia—Epirubicin—thyroid cancer	0.00149	0.00149	CcSEcCtD
Meropenem—Abdominal distension—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Meropenem—Asthma—Doxorubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Meropenem—Eosinophilia—Doxorubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Meropenem—Nausea—Sorafenib—thyroid cancer	0.00145	0.00145	CcSEcCtD
Meropenem—Pneumonia—Epirubicin—thyroid cancer	0.00143	0.00143	CcSEcCtD
Meropenem—Infestation NOS—Epirubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Meropenem—Infestation—Epirubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Meropenem—Renal failure—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Meropenem—Neuropathy peripheral—Epirubicin—thyroid cancer	0.00139	0.00139	CcSEcCtD
Meropenem—Jaundice—Epirubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Meropenem—Dysuria—Doxorubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Meropenem—Neutropenia—Doxorubicin—thyroid cancer	0.00138	0.00138	CcSEcCtD
Meropenem—Sweating—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Meropenem—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Meropenem—Epistaxis—Epirubicin—thyroid cancer	0.00134	0.00134	CcSEcCtD
Meropenem—Agranulocytosis—Epirubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Meropenem—Pneumonia—Doxorubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Meropenem—Infestation NOS—Doxorubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Meropenem—Infestation—Doxorubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Meropenem—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Meropenem—Bradycardia—Epirubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Meropenem—Renal failure—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Meropenem—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Meropenem—Haemoglobin—Epirubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Meropenem—Jaundice—Doxorubicin—thyroid cancer	0.00128	0.00128	CcSEcCtD
Meropenem—Haemorrhage—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Meropenem—Hepatitis—Epirubicin—thyroid cancer	0.00127	0.00127	CcSEcCtD
Meropenem—Pharyngitis—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Meropenem—Sweating—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Meropenem—Oedema peripheral—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—thyroid cancer	0.00124	0.00124	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Meropenem—Erythema multiforme—Epirubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—thyroid cancer	0.0012	0.0012	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Meropenem—Immune system disorder—Epirubicin—thyroid cancer	0.00115	0.00115	CcSEcCtD
Meropenem—Chills—Epirubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Meropenem—Erythema—Epirubicin—thyroid cancer	0.00111	0.00111	CcSEcCtD
Meropenem—Flatulence—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Meropenem—Tension—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Meropenem—Dysgeusia—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Meropenem—Nervousness—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Meropenem—Back pain—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Meropenem—Chills—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Meropenem—Erythema—Doxorubicin—thyroid cancer	0.00103	0.00103	CcSEcCtD
Meropenem—Anaemia—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Meropenem—Agitation—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Meropenem—Tension—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Meropenem—Malaise—Epirubicin—thyroid cancer	0.000999	0.000999	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—thyroid cancer	0.000996	0.000996	CcSEcCtD
Meropenem—Syncope—Epirubicin—thyroid cancer	0.000994	0.000994	CcSEcCtD
Meropenem—Leukopenia—Epirubicin—thyroid cancer	0.000992	0.000992	CcSEcCtD
Meropenem—Back pain—Doxorubicin—thyroid cancer	0.000992	0.000992	CcSEcCtD
Meropenem—Loss of consciousness—Epirubicin—thyroid cancer	0.000974	0.000974	CcSEcCtD
Meropenem—Cough—Epirubicin—thyroid cancer	0.000967	0.000967	CcSEcCtD
Meropenem—Hypertension—Epirubicin—thyroid cancer	0.000957	0.000957	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—thyroid cancer	0.000948	0.000948	CcSEcCtD
Meropenem—Chest pain—Epirubicin—thyroid cancer	0.000943	0.000943	CcSEcCtD
Meropenem—Agitation—Doxorubicin—thyroid cancer	0.000942	0.000942	CcSEcCtD
Meropenem—Anxiety—Epirubicin—thyroid cancer	0.00094	0.00094	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000937	0.000937	CcSEcCtD
Meropenem—Malaise—Doxorubicin—thyroid cancer	0.000925	0.000925	CcSEcCtD
Meropenem—Syncope—Doxorubicin—thyroid cancer	0.000919	0.000919	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—thyroid cancer	0.000918	0.000918	CcSEcCtD
Meropenem—Confusional state—Epirubicin—thyroid cancer	0.000912	0.000912	CcSEcCtD
Meropenem—Anaphylactic shock—Epirubicin—thyroid cancer	0.000904	0.000904	CcSEcCtD
Meropenem—Oedema—Epirubicin—thyroid cancer	0.000904	0.000904	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—thyroid cancer	0.000901	0.000901	CcSEcCtD
Meropenem—Infection—Epirubicin—thyroid cancer	0.000898	0.000898	CcSEcCtD
Meropenem—Cough—Doxorubicin—thyroid cancer	0.000895	0.000895	CcSEcCtD
Meropenem—Shock—Epirubicin—thyroid cancer	0.00089	0.00089	CcSEcCtD
Meropenem—Nervous system disorder—Epirubicin—thyroid cancer	0.000887	0.000887	CcSEcCtD
Meropenem—Thrombocytopenia—Epirubicin—thyroid cancer	0.000885	0.000885	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—thyroid cancer	0.000885	0.000885	CcSEcCtD
Meropenem—Tachycardia—Epirubicin—thyroid cancer	0.000883	0.000883	CcSEcCtD
Meropenem—Skin disorder—Epirubicin—thyroid cancer	0.000878	0.000878	CcSEcCtD
Meropenem—Hyperhidrosis—Epirubicin—thyroid cancer	0.000874	0.000874	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—thyroid cancer	0.000873	0.000873	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—thyroid cancer	0.00087	0.00087	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000867	0.000867	CcSEcCtD
Meropenem—Anorexia—Epirubicin—thyroid cancer	0.000862	0.000862	CcSEcCtD
Meropenem—Hypotension—Epirubicin—thyroid cancer	0.000845	0.000845	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—thyroid cancer	0.000844	0.000844	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000837	0.000837	CcSEcCtD
Meropenem—Oedema—Doxorubicin—thyroid cancer	0.000837	0.000837	CcSEcCtD
Meropenem—Infection—Doxorubicin—thyroid cancer	0.000831	0.000831	CcSEcCtD
Meropenem—Shock—Doxorubicin—thyroid cancer	0.000823	0.000823	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—thyroid cancer	0.000821	0.000821	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000819	0.000819	CcSEcCtD
Meropenem—Insomnia—Epirubicin—thyroid cancer	0.000818	0.000818	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—thyroid cancer	0.000817	0.000817	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—thyroid cancer	0.000813	0.000813	CcSEcCtD
Meropenem—Paraesthesia—Epirubicin—thyroid cancer	0.000812	0.000812	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000809	0.000809	CcSEcCtD
Meropenem—Dyspnoea—Epirubicin—thyroid cancer	0.000806	0.000806	CcSEcCtD
Meropenem—Somnolence—Epirubicin—thyroid cancer	0.000804	0.000804	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—thyroid cancer	0.000798	0.000798	CcSEcCtD
Meropenem—Dyspepsia—Epirubicin—thyroid cancer	0.000796	0.000796	CcSEcCtD
Meropenem—Decreased appetite—Epirubicin—thyroid cancer	0.000786	0.000786	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—thyroid cancer	0.000782	0.000782	CcSEcCtD
Meropenem—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000781	0.000781	CcSEcCtD
Meropenem—Pain—Epirubicin—thyroid cancer	0.000773	0.000773	CcSEcCtD
Meropenem—Constipation—Epirubicin—thyroid cancer	0.000773	0.000773	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—thyroid cancer	0.000757	0.000757	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—thyroid cancer	0.000751	0.000751	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—thyroid cancer	0.000746	0.000746	CcSEcCtD
Meropenem—Feeling abnormal—Epirubicin—thyroid cancer	0.000745	0.000745	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—thyroid cancer	0.000744	0.000744	CcSEcCtD
Meropenem—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000739	0.000739	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—thyroid cancer	0.000737	0.000737	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—thyroid cancer	0.000727	0.000727	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000722	0.000722	CcSEcCtD
Meropenem—Urticaria—Epirubicin—thyroid cancer	0.000718	0.000718	CcSEcCtD
Meropenem—Pain—Doxorubicin—thyroid cancer	0.000716	0.000716	CcSEcCtD
Meropenem—Constipation—Doxorubicin—thyroid cancer	0.000716	0.000716	CcSEcCtD
Meropenem—Body temperature increased—Epirubicin—thyroid cancer	0.000715	0.000715	CcSEcCtD
Meropenem—Abdominal pain—Epirubicin—thyroid cancer	0.000715	0.000715	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—thyroid cancer	0.00069	0.00069	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000684	0.000684	CcSEcCtD
Meropenem—Hypersensitivity—Epirubicin—thyroid cancer	0.000666	0.000666	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—thyroid cancer	0.000665	0.000665	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—thyroid cancer	0.000661	0.000661	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—thyroid cancer	0.000661	0.000661	CcSEcCtD
Meropenem—Asthenia—Epirubicin—thyroid cancer	0.000649	0.000649	CcSEcCtD
Meropenem—Pruritus—Epirubicin—thyroid cancer	0.00064	0.00064	CcSEcCtD
Meropenem—Diarrhoea—Epirubicin—thyroid cancer	0.000619	0.000619	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—thyroid cancer	0.000616	0.000616	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—thyroid cancer	0.0006	0.0006	CcSEcCtD
Meropenem—Dizziness—Epirubicin—thyroid cancer	0.000598	0.000598	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—thyroid cancer	0.000592	0.000592	CcSEcCtD
Meropenem—Vomiting—Epirubicin—thyroid cancer	0.000575	0.000575	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—thyroid cancer	0.000572	0.000572	CcSEcCtD
Meropenem—Rash—Epirubicin—thyroid cancer	0.00057	0.00057	CcSEcCtD
Meropenem—Dermatitis—Epirubicin—thyroid cancer	0.00057	0.00057	CcSEcCtD
Meropenem—Headache—Epirubicin—thyroid cancer	0.000567	0.000567	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—thyroid cancer	0.000553	0.000553	CcSEcCtD
Meropenem—Nausea—Epirubicin—thyroid cancer	0.000537	0.000537	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—thyroid cancer	0.000532	0.000532	CcSEcCtD
Meropenem—Rash—Doxorubicin—thyroid cancer	0.000528	0.000528	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—thyroid cancer	0.000527	0.000527	CcSEcCtD
Meropenem—Headache—Doxorubicin—thyroid cancer	0.000524	0.000524	CcSEcCtD
Meropenem—Nausea—Doxorubicin—thyroid cancer	0.000497	0.000497	CcSEcCtD
